| The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis YL Zhang, JQ Yuan, KF Wang, XH Fu, XR Han, D Threapleton, ZY Yang, ... Oncotarget 7 (48), 78985, 2016 | 711 | 2016 |
| Resistance exercise versus aerobic exercise for type 2 diabetes: a systematic review and meta-analysis Z Yang, CA Scott, C Mao, J Tang, AJ Farmer Sports medicine 44, 487-499, 2014 | 451 | 2014 |
| Prevalence of anxiety and depression symptom, and the demands for psychological knowledge and interventions in college students during COVID-19 epidemic: A large cross … ZH Wang, HL Yang, YQ Yang, D Liu, ZH Li, XR Zhang, YJ Zhang, D Shen, ... Journal of affective disorders 275, 188-193, 2020 | 383 | 2020 |
| KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: a meta-analysis of 22 studies C Mao, LX Qiu, RY Liao, FB Du, H Ding, WC Yang, J Li, Q Chen Lung cancer 69 (3), 272-278, 2010 | 379 | 2010 |
| Depression and risk of stroke: a meta-analysis of prospective studies JY Dong, YH Zhang, J Tong, LQ Qin Stroke 43 (1), 32-37, 2012 | 372 | 2012 |
| Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis JQ Yuan, RJ Zhang, ZY Yang, J Lee, YL Liu, JH Tian, XW Qin, ZJ Ren, ... European urology 63 (5), 902-912, 2013 | 290 | 2013 |
| Contact settings and risk for transmission in 3410 close contacts of patients with COVID-19 in Guangzhou, China: a prospective cohort study L Luo, D Liu, X Liao, X Wu, Q Jing, J Zheng, F Liu, S Yang, H Bi, Z Li, J Liu, ... Annals of internal medicine 173 (11), 879-887, 2020 | 269 | 2020 |
| Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis BZ Li, DE Threapleton, JY Wang, JM Xu, JQ Yuan, C Zhang, P Li, QL Ye, ... Bmj 351, 2015 | 229 | 2015 |
| PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta … C Mao, ZY Yang, XF Hu, Q Chen, JL Tang Annals of oncology 23 (6), 1518-1525, 2012 | 223 | 2012 |
| Modes of contact and risk of transmission in COVID-19 among close contacts L Luo, D Liu, X Liao, X Wu, Q Jing, J Zheng, F Liu, S Yang, B Bi, Z Li, J Liu, ... MedRxiv, 2020.03. 24.20042606, 2020 | 172 | 2020 |
| Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis KSL Wong, Y Wang, X Leng, C Mao, J Tang, PMW Bath, HS Markus, ... Circulation 128 (15), 1656-1666, 2013 | 156 | 2013 |
| Impact of collaterals on the efficacy and safety of endovascular treatment in acute ischaemic stroke: a systematic review and meta-analysis X Leng, H Fang, TWH Leung, C Mao, Z Miao, L Liu, KS Wong, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (5), 537-544, 2016 | 145 | 2016 |
| Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: a meta-analysis of 22 studies LX Qiu, C Mao, J Zhang, XD Zhu, RY Liao, K Xue, J Li, Q Chen European Journal of Cancer 46 (15), 2781-2787, 2010 | 124 | 2010 |
| Concordant analysis of KRAS, BRAF, PIK3CA mutations and PTEN expression between primary colorectal cancer and matched metastases C Mao, XY Wu, ZY Yang, DE Threapleton, JQ Yuan, YY Yu, JL Tang Scientific reports 5 (1), 8065, 2015 | 112 | 2015 |
| Impact of collateral status on successful revascularization in endovascular treatment: a systematic review and meta-analysis X Leng, H Fang, TWH Leung, C Mao, Y Xu, Z Miao, L Liu, KSL Wong, ... Cerebrovascular Diseases 41 (1-2), 27-34, 2016 | 111 | 2016 |
| BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis C Mao, RY Liao, LX Qiu, XW Wang, H Ding, Q Chen Molecular biology reports 38, 2219-2223, 2011 | 111 | 2011 |
| Yoga for asthma ZY Yang, HB Zhong, C Mao, JQ Yuan, Y Huang, XY Wu, YM Gao, JL Tang Cochrane Database of Systematic Reviews, 2016 | 108 | 2016 |
| KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: A systematic … C Mao, YF Huang, ZY Yang, DY Zheng, JZ Chen, JL Tang Cancer 119 (4), 714-721, 2013 | 108 | 2013 |
| Promising biomarkers for predicting the outcomes of patients with KRAS wild‐type metastatic colorectal cancer treated with anti‐epidermal growth factor receptor … ZY Yang, XY Wu, YF Huang, MY Di, DY Zheng, JZ Chen, H Ding, C Mao, ... International journal of cancer 133 (8), 1914-1925, 2013 | 91 | 2013 |
| KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with colorectal cancer C Mao, J Zhou, Z Yang, Y Huang, X Wu, H Shen, J Tang, Q Chen PloS one 7 (5), e36653, 2012 | 84 | 2012 |
